Circulating levels of osteoprotegerin and sRANKL and the effect of methotrexate in patients with rheumatoid arthritis
Background: Receptor activator of nuclear factor κβ ligand (RANKL) and osteoprotegerin (OPG) are pivotal molecules involved in osteoclast activation and resorption. In RA, their alterations mediated through inflammatory cytokines are responsible for erosions and systemic bone loss. This study planne...
Saved in:
| Main Authors: | Aadhaar Dhooria, Narendhiran Pandurangan, Karthik Vinay Mahesh, Suchet Sachdev, Aman Sharma, Shefali Sharma, Nidhi Gupta, Varun Dhir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=2;spage=90;epage=94;aulast=Dhooria |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE ROLE OF OSTEOPROTEGERIN SYSTEM /RANKL/RANK IN PATHOGENESIS OF AORTIC STENOSIS
by: O. B. Irtyuga, et al.
Published: (2018-03-01) -
EFFECT OF INFLIXIMAB ON PARAMETERS OF REMODELING OF ARTERIAL BLOODSTREAM, RANKL AND OSTEOPROTEGERIN LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Larisa Aleksandrovna Knyazeva, et al.
Published: (2014-02-01) -
Investigating the role of osteoprotegerin gene polymorphic variants in osteoporosis
by: Bulat I. Yalaev, et al.
Published: (2021-03-01) -
The role of osteoprotegerin (OPG) in exercise-induced skeletal muscle adaptation
by: Owens Aaron, et al.
Published: (2024-12-01) -
Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis
by: A. T. Teplyakov, et al.
Published: (2018-12-01)